Patent · US Active

Methods of treating breast cancer

US12048732B2 · kind B2 · utility

0Cited by
49References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2017
Grant dateJul 30, 2024
Priority date
Expiry dateApr 14, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/43522
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and formulations comprising chlorotoxin conjugate compounds are provided, including native and modified variants of chlorotoxin peptide conjugated to detectable agents or active agents. Methods of detecting and treating ductal carcinoma in situ breast cancer, invasive ductal carcinoma breast cancer, lobular carcinoma in situ, invasive lobular carcinoma, and triple-negative breast cancer with chlorotoxin conjugate compounds are also provided, including methods of imaging tumor tissues and cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.